XML 67 R65.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

ACQUISITIONS AND LICENSING AGREEMENTS - Narrative (Details) business in Thousands |  |  | 10 Months Ended | 12 Months Ended | 34 Months Ended |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | ---
Mar. 06, 2019 USD ($) | Oct. 16, 2018 USD ($) | Dec. 31, 2019 USD ($) | Dec. 31, 2019 USD ($) business | Dec. 31, 2018 USD ($) business | Dec. 31, 2017 USD ($) business | Dec. 31, 2019 USD ($) | Sep. 30, 2018 USD ($) | Mar. 31, 2017 USD ($) | Feb. 21, 2017 USD ($)
Business Combinations |  |  |  |  |  |  |  |  |  |
Other expense |  |  |  | $ 1,414,000,000 | $ (20,000,000) | $ (348,000,000) |  |  |  |
Reduction of additional paid-in capital |  |  |  |  | $ 18,000,000 | $ 9,000,000 |  |  |  |
Number of other material business combinations | business |  |  |  | 0 |  |  |  |  |  |
Number of material business combinations | business |  |  |  |  | 0 | 0 |  |  |  |
Payment for contingent consideration liability |  |  |  | $ 35,000,000 | $ 37,000,000 | $ 45,000,000 |  |  |  |
Additional Paid-In Capital |  |  |  |  |  |  |  |  |  |
Business Combinations |  |  |  |  |  |  |  |  |  |
Reduction of additional paid-in capital |  |  |  |  | 15,000,000 | $ 2,000,000 |  |  |  |
Synergy |  |  |  |  |  |  |  |  |  |
Business Combinations |  |  |  |  |  |  |  |  |  |
Cash payments to acquire certain assets and assumed liabilities | $ 180,000,000 |  |  |  |  |  |  |  |  |
Revenue of acquiree since acquisition date |  |  | $ 55,000,000 |  |  |  |  |  |  |
Operating results of acquiree since acquisition |  |  | $ 0 |  |  |  |  |  |  |
Pro-forma revenue |  |  |  | 0 | 0 |  |  |  |  |
Pro-forma operating results |  |  |  | 0 | $ 0 |  |  |  |  |
Other expense |  |  |  | $ 8,000,000 |  |  |  |  |  |
Medpharma |  |  |  |  |  |  |  |  |  |
Business Combinations |  |  |  |  |  |  |  |  |  |
Cash payments to acquire certain assets and assumed liabilities |  | $ 18,000,000 |  |  |  |  |  |  |  |
Percentage interest acquired |  | 40.00% |  |  |  |  |  |  |  |
Medpharma | Additional Paid-In Capital |  |  |  |  |  |  |  |  |  |
Business Combinations |  |  |  |  |  |  |  |  |  |
Reduction of additional paid-in capital |  | $ 15,000,000 |  |  |  |  |  |  |  |
EyeGate | Development and Regulatory Milestones |  |  |  |  |  |  |  |  |  |
Business Combinations |  |  |  |  |  |  |  |  |  |
Upfront payment |  |  |  |  |  |  |  |  | $ 4,000,000 |
Possible contingent consideration (up to) |  |  |  |  |  |  |  |  |  | $ 34,000,000
Payment for contingent consideration liability |  |  |  |  |  |  | $ 3,000,000 |  |  |
Carrying value, contingent consideration, liability |  |  |  |  |  |  |  | $ 0 |  |
EyeGate | Sales Based Milestone Payments |  |  |  |  |  |  |  |  |  |
Business Combinations |  |  |  |  |  |  |  |  |  |
Possible contingent consideration (up to) |  |  |  |  |  |  |  |  |  | $ 65,000,000

X
- Definition Business Acquisition, Pro Forma Operating Income (Loss) + References No definition available. + Details
Name: | bhc_BusinessAcquisitionProFormaOperatingIncomeLoss
Namespace Prefix: | bhc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represents the upfront payment made for business acquisition. + References No definition available. + Details
Name: | bhc_BusinessAcquisitionPurchasePriceUpfrontPayment
Namespace Prefix: | bhc_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Business Combination, Pro Forma Information, Operating Income (Loss) Since Acquisition, Actual + References No definition available. + Details
Name: | bhc_BusinessCombinationProFormaInformationOperatingIncomeLossSinceAcquisitionActual
Namespace Prefix: | bhc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number Of Other Businesses Acquired + References No definition available. + Details
Name: | bhc_NumberOfOtherBusinessesAcquired
Namespace Prefix: | bhc_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(3) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessAcquisitionsProFormaRevenue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c)(3) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of liability recognized arising from contingent consideration in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 35 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 23 -URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569655-111683 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4616395-111683 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 + Details
Name: | us-gaap_MinorityInterestDecreaseFromRedemptions
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of businesses acquired by the entity during the period. + References No definition available. + Details
Name: | us-gaap_NumberOfBusinessesAcquired
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of income (expense) related to nonoperating activities, classified as other. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.9) -URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227 + Details
Name: | us-gaap_OtherNonoperatingIncomeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585 + Details
Name: | us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b)(1) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=bhc_SynergyPharmaceuticalsInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=bhc_MedpharmaPharmaceuticalChemicalIndustriesLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=bhc_EyeGateIIDeliverySystemAndEGP437Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=bhc_DevelopmentAndRegulatoryMilestonesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=bhc_SalesBasedMilestonePaymentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |